Accountable Care Organizations (ACOs) face several challenges that can impact the quality and effectiveness of care for their patients with Chronic Obstructive Pulmonary Disease (COPD). Here are the seven common challenges that we hear frequently cited by ACO leaders.
Spirometry is a diagnostic test used to assess lung function by measuring the volume and flow of air during breathing. While spirometry itself does not directly address medication adherence or inhaler technique, it can provide valuable information that can aid in evaluating and improving these aspects of respiratory care.
It’s World Asthma Day (May 2, 2023), which is organized by the Global Initiative for Asthma, (GINA), a World Health Organization collaborative organization. If you are a primary care provider, it’s a great chance to reflect on the crucial role you play in managing your patients' asthma. One tool that can help you provide effective care and improve outcomes is the Asthma Action Plan developed by the National Heart, Lung & Blood Institute (NHLBI).
Every May, we turn our attention to the people living with asthma and allergies and the people who support and care for them. Since 1984, the Asthma and Allergy Foundation of America (AAFA) has declared May to be “National Asthma and Allergy Awareness Month.” On a near-daily basis, the team at VitalFlo hears first-hand about the impact that asthma and allergies take on both patients and providers.
VitalFlo today announced that it has partnered with Vitalograph to provide smart respiratory health monitoring through Vitalograph's range of remote monitoring spirometry devices. This exciting partnership enables patients to perform reliable lung function tests anytime, anywhere as a critical element in the ongoing management of their respiratory health.
How to understand Spirometry Predictive Equations, such as NHANES III vs. GLI 12, in order to decide which is most appropriate for your patients
Raleigh, NC - July 13, 2021 - VitalFlo, the predictive medicine platform for chronic respiratory diseases such as asthma and COPD, today announced it has secured $2.14 million in seed funding led by Geekdom Fund, who were joined by Elevate Capital, Lontra Ventures, Front Porch Venture Partners, and Purpose Built Ventures.
This is a question that frequently enters the mind of non-profit program managers, healthcare professionals, product managers, school principals, the list goes on. The key word to this title, however, is how does one do this effectively? Sure, asking questions is easy, but how do you know they’re even the right questions?
As an asthma forecasting company, we strive to reduce the burden of asthma so that patients can better prepare for the possibility of an exacerbation. We do so based on forecasting asthma control based on weather, pollution, previous spirometry measures, and most recently, previous days of asthma control.
A little over a week ago I summarized some of America’s history that disadvantaged marginalized racial groups. Today I’ll dive into how spirometry equations are created, and next week we’ll dive into how history embeds itself into spirometry as well.
When I started working at VitalFlo, I noticed in the universally used algorithms developed from clinical research that exist for predicting lung health, race or ethnicity is a necessary factor for the equation. As a healthcare company, we have an ethical responsibility for understanding the nuance of how our product is used, its effects on the health of our patients, and the implications of the readings of our product puts forth.